Alzheimer Disease

Displaying 1 - 50 of 328CSV
Fleming, V. L., Helsel, B. C., Ptomey, L. T., Handen, B. L., Krinsky‐McHale, S. J., Hom, C. L., Zammit, M., Minhas, D., Luo, W., Laymon, C., Lee, J. H., Lott, I., Cohen, A., Ances, B. M., Brickman, A. M., Pulsifer, M., Clare, I. C. H., Rosa, H. D., … Lai, F. (2025). Longitudinal study of body mass index in relation to Alzheimer’s disease pathology and symptomatology in Down syndrome. Alzheimer’s & Dementia, 21(6). Portico. https://doi.org/10.1002/alz.70387
Publication Date
Hu, T., Liu, Q., Dai, Q., Buchman, A. S., Bennett, D. A., Tasaki, S., Wang, Y., Seyfried, N. T., De Jager, P. L., Epstein, M. P., & Yang, J. (2025). Proteome-wide association studies using summary pQTL data of brain, CSF, and plasma identify 30 risk genes of Alzheimer’s disease dementia. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01774-y
Publication Date
Lee, H., Tzuang, M., Chow, T. W., Kang, Y., Tee, B. L., Li, C., Lam, E., Gu, Y., Lee, S., Ho, P., Peavy, G., Seo, E. H., Kim, K., Tran, B., Chae, W., Nguyen, D., Vo, N., Dang, D., … Spat‐Lemus, J. (2025). Translation and cultural adaptation of tools to assess diverse Asian American and Asian Canadian subgroups: The Asian Cohort for Alzheimer’s Disease (ACAD) Study. Alzheimer’s & Dementia, 21(6). Portico. https://doi.org/10.1002/alz.70311
Publication Date
Wang, H., Dombroski, B. A., Cheng, P., Tucci, A., Si, Y., Farrell, J. J., Tzeng, J., Leung, Y. Y., Malamon, J. S., Wang, L., Vardarajan, B. N., Farrer, L. A., Schellenberg, G. D., & Lee, W. (2025). Structural variation detection and association analysis of whole‐genome‐sequence data from 16,543 Alzheimer’s disease sequencing project subjects. Alzheimer’s & Dementia, 21(6). Portico. https://doi.org/10.1002/alz.70277
Publication Date
Lee, S., Hecker, J., Vardarajan, B. N., Kelly, R. S., Prince, N., Mullin, K., Lutz, S. M., Hahn, G., Lasky‐Su, J., Mayeux, R. P., Tanzi, R. E., Lange, C., & Prokopenko, D. (2025). Uncovering Ethnicity‐Specific Recessive Loci for Alzheimer’s Disease in 89 Dominican Families Using Family‐Based WGS Analysis. Genetic Epidemiology, 49(5). Portico. https://doi.org/10.1002/gepi.70014
Publication Date
Lish, A. M., Ashour, N., Pearse, R. V., Galle, P. C., Orme, G. A., Heuer, S. E., Benoit, C. R., Alexander, K. D., Grogan, E. F. L., Terzioglu, G., Scarpa, A., Stern, A. M., Seyfried, N., Menon, V., & Young-Pearse, T. L. (2025). Astrocyte induction of disease-associated microglia is suppressed by acute exposure to fAD neurons in human iPSC triple cultures. Cell Reports, 44(6), 115777. https://doi.org/10.1016/j.celrep.2025.115777
Publication Date
Gholampour, M., Basu, M. K., Swerdlow, R. H., Zhuo, X., & Haeri, M. (2025). Cell‐specific protein expression in Alzheimer’s disease prefrontal cortex. Alzheimer’s & Dementia, 21(6). Portico. https://doi.org/10.1002/alz.70339
Publication Date
Chen, C. D., Franklin, E. E., Li, Y., Joseph-Mathurin, N., Burns, A. L., Hobbs, D. A., McCullough, A. A., Schultz, S. A., Xiong, C., Wang, G., Masellis, M., Hsiung, G.-Y. R., Gauthier, S., Berman, S. B., Roberson, E. D., Honig, L. S., Clarnette, R., Ringman, J. M., Galvin, J. E., … Mori, H. (2025). Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease. Acta Neuropathologica, 149(1). https://doi.org/10.1007/s00401-025-02890-7
Publication Date
Luchsinger, J. A., Devanand, D., Goldberg, T. E., Cammack, S., Hernández-Santiago, G., Oishi, K., Jagust, W., Baker, S., Landau, S., Yenokyan, G., Betz, J., Mayers, S., Eyzaguirre, L. M., & Hanley, D. (2025). Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders, 39(2), 123–133. https://doi.org/10.1097/wad.0000000000000677
Publication Date
Leung, Y. Y., Lee, W., Kuzma, A. B., Nicaretta, H., Valladares, O., Gangadharan, P., Qu, L., Zhao, Y., Ren, Y., Cheng, P., Kuksa, P. P., Wang, H., White, H., Katanic, Z., Bass, L., Saravanan, N., Greenfest‐Allen, E., Kirsch, M., Cantwell, L., … Wang, L. (2025). Alzheimer’s Disease Sequencing Project release 4 whole genome sequencing dataset. Alzheimer’s & Dementia, 21(5). Portico. https://doi.org/10.1002/alz.70237
Publication Date
Handen, B. L., Mapstone, M., Hartley, S., Andrews, H., Christian, B., Lee, J. H., Tudorascu, D., Hom, C., Ances, B. M., Zaman, S., Krinsky‐McHale, S., Brickman, A. M., Rosas, H. D., Cohen, A., Petersen, M., O’Bryant, S., Harp, J. P., Schmitt, F., … Ptomey, L. (2025). The Alzheimer’s Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year report. Alzheimer’s & Dementia, 21(5). Portico. https://doi.org/10.1002/alz.70294
Publication Date
Williams, J. R., DeConne, T. M., Pewowaruk, R., Korcarz, C., Tanley, J., Carlsson, C., Heckbert, S. R., Habes, M., Nasrallah, I., Lockhart, S. N., Luchsinger, J. A., Ding, J., Hayden, K. M., Hughes, T. M., & Gepner, A. D. (2025). Total and Structural Carotid Artery Stiffness Are Associated With Cognitive Decline and Structural Brain Abnormalities Related to Alzheimer Disease and Alzheimer Disease‐Related Dementias Pathology: The Multi‐Ethnic Study of Atherosclerosis. Journal of the American Heart Association, 14(9). https://doi.org/10.1161/jaha.124.039925
Publication Date
Barry, A., Peven, J. C., Handen, B. L., Bolt, D., Krinsky‐McHale, S. J., Hom, C. L., Clare, I. C. H., Glueck, A., Harp, J., Schmitt, F., Zammit, M., Minhas, D., Luo, W., Laymon, C., Price, J., Lee, J. H., Lott, I., Cohen, A., … Ances, B. M. (2025). Longitudinal investigation of gait and Alzheimer’s disease in adults with Down syndrome. Alzheimer’s & Dementia, 21(4). Portico. https://doi.org/10.1002/alz.70211
Publication Date
Boyle, R., Koops, E. A., Ances, B., Andrews, E. J., Arenaza‐Urquijo, E. M., Benjanin, A., Brickman, A. M., Buckley, R. F., Clas, G. S., Costello, E., Coughlan, G. T., Conley, A. C., Deng, F., de Paula Faria, D., Edwards, N., Flores‐Aguilar, L., Fortea, J., Ghazi Saidi, L., Head, E., … Hartley, S. (2025). Resistance and resilience to Alzheimer’s disease in Down syndrome. Alzheimer’s & Dementia, 21(4). Portico. https://doi.org/10.1002/alz.70151
Publication Date
Barral, S., Yang, Z., Phillips, N., Barber, R. C., Brickman, A. M., Honig, L. S., Cieza, B., Reyes‐Dumeyer, D., Mayeux, R., Rajabli, F., Cuccaro, M. L., Vance, J. M., Arango, S. M., Samper‐Ternent, R., Obregon, A. M., Montesinos, R., Soto‐Añari, M., Duran, J. C., Cusicanqui, M., … Tosto, G. (2025). APOE and Alzheimer’s disease and related dementias risk among 12,221 Hispanics/Latinos. Alzheimer’s & Dementia, 21(4). Portico. https://doi.org/10.1002/alz.70138
Publication Date
Jenkins, M. R., Peven, J. C., Kubic, L., Handen, B. L., Krinsky-McHale, S. J., Hom, C. L., Lee, A., Tudorascu, D. L., McLachlan, M., Zammit, M., Minhas, D., Luo, W., Laymon, C., Lee, J. H., Lott, I., Cohen, A., Ances, B. M., Rosas, H. D., … Lai, F. (2025). Behavioral and psychological symptoms of dementia and Alzheimer’s disease progression in Down syndrome. Journal of Neurodevelopmental Disorders, 17(1). https://doi.org/10.1186/s11689-025-09604-w
Publication Date
Yoon, S., Crupi, R., Sun, F., Tipiani, D., Patterson, M., Pottinger, T., Kim, M., & Davis, N. (2025). Comparing Emotional Valence from Human Quantitative Ratings and Qualitative Narrative Data on Using Artificial Intelligence to Reduce Caregiving Disparity. Envisioning the Future of Health Informatics and Digital Health. https://doi.org/10.3233/shti250036
Publication Date
Herline-Killian, K., Pauers, M. M., Lipponen, J. E., Zrzavy, M. A., Gouveia Roque, C., McCurdy, E. P., Chung, K. M., & Hengst, U. (2025). Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer’s disease pathology. Cell Death & Disease, 16(1). https://doi.org/10.1038/s41419-025-07586-0
Publication Date
Echeverry‐Quiceno, L. M., Llambrich, S., Heredia‐Lidón, Á., Giménez, S., Rozalem‐Aranha, M., Inampudi, P., Heuzé, Y., Sevillano, X., Fortea, J., & Martínez‐Abadías, N. (2025). Potential of facial biomarkers for Alzheimer’s disease and obstructive sleep apnea in Down syndrome and general population. The FASEB Journal, 39(6). Portico. https://doi.org/10.1096/fj.202403009r
Publication Date
Columbia Affiliation
Bateman, R. J., Li, Y., McDade, E. M., Llibre-Guerra, J. J., Clifford, D. B., Atri, A., Mills, S. L., Santacruz, A. M., Wang, G., Supnet, C., Benzinger, T. L. S., Gordon, B. A., Ibanez, L., Klein, G., Baudler, M., Doody, R. S., Delmar, P., Kerchner, G. A., Bittner, T., … Schofield, P. R. (2025). Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. The Lancet Neurology, 24(4), 316–330. https://doi.org/10.1016/s1474-4422(25)00024-9
Publication Date
Zhao, J., Gu, T., Gao, C., Miao, G., Palma-Gudiel, H., Yu, L., Yang, J., Wang, Y., Li, Y., Lim, J., Li, R., Yao, B., Wu, H., Schneider, J. A., Seyfried, N., Grodstein, F., De Jager, P. L., Jin, P., & Bennett, D. A. (2025). Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer’s disease neuropathology. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58159-w
Publication Date
Fioriti, L., Wijesekara, N., Argyrousi, E. K., Matsuzaki, S., Takamura, H., Satoh, K., Han, K., Yamauchi, H., Staniszewski, A., Acquarone, E., Orsini, F., Martucci, A., Katayama, T., Arancio, O., & Fraser, P. E. (2025). Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer’s disease. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.70030
Publication Date
Vialle, R. A., de Paiva Lopes, K., Li, Y., Ng, B., Schneider, J. A., Buchman, A. S., Wang, Y., Farfel, J. M., Barnes, L. L., Wingo, A. P., Wingo, T. S., Seyfried, N. T., De Jager, P. L., Gaiteri, C., Tasaki, S., & Bennett, D. A. (2025). Structural variants linked to Alzheimer’s disease and other common age-related clinical and neuropathologic traits. Genome Medicine, 17(1). https://doi.org/10.1186/s13073-025-01444-6
Publication Date
Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. (2025). Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.14528
Publication Date
Reho, P., Kalia, V., Jackson, G. L., Wang, F., Eiten, E., Brennan, K., Brickman, A. M., Mayeux, R., Miller, G. W., Vardarajan, B. N., Baccarelli, A., & Wu, H. (2025). Preclinical Alzheimer’s disease shows alterations in circulating neuronal‐derived extracellular vesicle microRNAs in a multiethnic cohort. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.70050
Publication Date
Arnold, M., Buyukozkan, M., Doraiswamy, P. M., Nho, K., Wu, T., Gudnason, V., Launer, L. J., Wang-Sattler, R., Adamski, J., De Jager, P. L., Ertekin-Taner, N., Bennett, D. A., Saykin, A. J., Peters, A., Suhre, K., Kaddurah-Daouk, R., Kastenmüller, G., & Krumsiek, J. (2025). Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57032-0
Publication Date
Dong, S., Braun, D., Wu, X., Yitshak-Sade, M., Blacker, D., Kioumourtzoglou, M.-A., Schwartz, J., Mork, D., Dominici, F., & Zanobetti, A. (2025). The impacts of air pollution on mortality and hospital readmission among Medicare beneficiaries with Alzheimer’s disease and Alzheimer’s disease-related dementias: a national retrospective cohort study in the USA. The Lancet Planetary Health, 9(2), e114–e123. https://doi.org/10.1016/s2542-5196(25)00001-4
Publication Date
Katsumi, Y., Touroutoglou, A., Brickhouse, M., Eloyan, A., Eckbo, R., Zaitsev, A., La Joie, R., Lagarde, J., Schonhaut, D., Thangarajah, M., Taurone, A., Vemuri, P., Jack, C. R., Dage, J. L., Nudelman, K. N. H., Foroud, T., Hammers, D. B., Ghetti, B., … Murray, M. E. (2025). Dissociable spatial topography of cortical atrophy in early‐onset and late‐onset Alzheimer’s disease: A head‐to‐head comparison of the LEADS and ADNI cohorts. Alzheimer’s & Dementia, 21(2). Portico. https://doi.org/10.1002/alz.14489
Publication Date
Putcha, D., Katsumi, Y., Touroutoglou, A., Eloyan, A., Taurone, A., Thangarajah, M., Aisen, P., Dage, J. L., Foroud, T., Jack, C. R., Kramer, J. H., Nudelman, K. N. H., Raman, R., Vemuri, P., Atri, A., Day, G. S., Duara, R., Graff-Radford, N. R., Grant, I. M., … Honig, L. S. (2025). Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01689-8
Publication Date
Mielke, M. M., Evans, J. K., Neiberg, R. H., Molina-Henry, D. P., Marcovina, S. M., Johnson, K. C., Carmichael, O. T., Rapp, S. R., Sachs, B. C., Ding, J., Shappell, H. M., Luchsinger, J. A., Espeland, M. A., & Hayden, K. M. (2025). Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity. JAMA Network Open, 8(2), e2458149. https://doi.org/10.1001/jamanetworkopen.2024.58149
Publication Date
Guo, M. H., Lee, W.-P., Vardarajan, B., Schellenberg, G. D., & Phillips-Cremins, J. E. (2025). Polygenic burden of short tandem repeat expansions promotes risk for Alzheimer’s disease. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-56400-0
Publication Date
Elyaman, W., Stern, L. J., Jiang, N., Dressman, D., Bradley, P., Klatzmann, D., Bradshaw, E. M., Farber, D. L., Kent, S. C., Chizari, S., Funk, K., Devanand, D., Thakur, K. T., Raj, T., Dalahmah, O. A., Sarkis, R. A., Weiner, H. L., Shneider, N. A., & Przedborski, S. (2025). Exploring the role of T cells in Alzheimer’s and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14548
Publication Date
Pandey, N., Yang, Z., Cieza, B., Reyes-Dumeyer, D., Kang, M. S., Montesinos, R., Soto-Añari, M., Custodio, N., Honig, L. S., & Tosto, G. (2025). Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-024-01655-w
Publication Date
Siemers, E., Feaster, T., Sethuraman, G., Sundell, K., Skljarevski, V., Cline, E. N., Zhang, H., Jerecic, J., Honig, L. S., Salloway, S., Sperling, R., Trame, M. N., Dodds, M. G., & Johnson, K. (2025). INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The Journal of Prevention of Alzheimer’s Disease, 12(1), 100005. https://doi.org/10.1016/j.tjpad.2024.100005
Publication Date
Hammers, D. B., Eloyan, A., Thangarajah, M., Taurone, A., Beckett, L., Gao, S., Polsinelli, A. J., Kirby, K., Dage, J. L., Nudelman, K., Aisen, P., Reman, R., La Joie, R., Lagarde, J., Atri, A., Clark, D., Day, G. S., Duara, R., … Graff‐Radford, N. R. (2024). Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer’s disease: Comparison of LEADS and ADNI. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14218
Publication Date
Hammers, D. B., Eloyan, A., Taurone, A., Thangarajah, M., Gao, S., Beckett, L., Polsinelli, A. J., Kirby, K., Dage, J. L., Nudelman, K., Aisen, P., Reman, R., La Joie, R., Lagarde, J., Atri, A., Clark, D., Day, G. S., Duara, R., … Graff‐Radford, N. R. (2024). Longitudinal cognitive performance of participants with sporadic early onset Alzheimer’s disease from LEADS. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14439
Publication Date
Yao, M., Miller, G. W., Vardarajan, B. N., Baccarelli, A. A., Guo, Z., & Liu, Z. (2024). Deciphering proteins in Alzheimer’s disease: A new Mendelian randomization method integrated with AlphaFold3 for 3D structure prediction. Cell Genomics, 4(12), 100700. https://doi.org/10.1016/j.xgen.2024.100700
Publication Date
Wu, Y., Libby, J. B., Dumitrescu, L., De Jager, P. L., Menon, V., Schneider, J. A., Bennett, D. A., & Hohman, T. J. (2024). Association of ten VEGF family genes with Alzheimer’s disease endophenotypes at single cell resolution. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14419
Publication Date
Roy, N., Haq, I., Ngo, J. C., Bennett, D. A., Teich, A. F., De Jager, P. L., Olah, M., & Sher, F. (2024). Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02835-6
Publication Date
Fowler, S. L., Behr, T. S., Turkes, E., O’Brien, D. P., Cauhy, P. M., Rawlinson, I., Edmonds, M., Foiani, M. S., Schaler, A., Crowley, G., Bez, S., Ficulle, E., Tsefou, E., Fischer, R., Geary, B., Gaur, P., Miller, C., D’Acunzo, P., Levy, E., … Ryskeldi-Falcon, B. (2024). Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease. Nature Neuroscience. https://doi.org/10.1038/s41593-024-01801-5
Publication Date
Vockert, N., Machts, J., Kleineidam, L., Nemali, A., Incesoy, E. I., Bernal, J., Schütze, H., Yakupov, R., Peters, O., Gref, D., Schneider, L. S., Preis, L., Priller, J., Spruth, E. J., Altenstein, S., Schneider, A., Fliessbach, K., Wiltfang, J., … Rostamzadeh, A. (2024). Cognitive reserve against Alzheimer’s pathology is linked to brain activity during memory formation. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-53360-9
Publication Date
Boerwinkle, A. H., Wisch, J. K., Handen, B. L., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S. E., Krinsky‐McHale, S. J., Lai, F., Rosas, H. D., Zaman, S., Lott, I. T., Tudorascu, D., Zammit, M., Brickman, A. M., Lee, J. H., & Ances, B. M. (2024). The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down’s syndrome. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14359
Publication Date
Seifar, F., Fox, E. J., Shantaraman, A., Liu, Y., Dammer, E. B., Modeste, E., Duong, D. M., Yin, L., Trautwig, A. N., Guo, Q., Xu, K., Ping, L., Reddy, J. S., Allen, M., Quicksall, Z., Heath, L., Scanlan, J., Wang, E., Wang, M., … Seyfried, N. T. (2024). Large‐scale deep proteomic analysis in Alzheimer’s disease brain regions across race and ethnicity. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14360
Publication Date
Roberts, J. A., Varma, V. R., Jones, A., & Thambisetty, M. (2024). Drug Repurposing for Effective Alzheimer’s Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches. Journal of Alzheimer’s Disease, 101(s1), S299–S315. https://doi.org/10.3233/jad-240680
Publication Date
Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024). Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. Journal of Alzheimer’s Disease, 101(s1), S345–S356. https://doi.org/10.3233/jad-240495
Publication Date
Jones, A. A., Ramos‐Miguel, A., Gicas, K. M., Petyuk, V. A., Leurgans, S. E., De Jager, P. L., Schneider, J. A., Bennett, D. A., Honer, W. G., & Casaletto, K. B. (2024). A multilayer network analysis of Alzheimer’s disease pathogenesis: Roles for p‐tau, synaptic peptides, and physical activity. Alzheimer’s & Dementia, 20(11), 8012–8027. Portico. https://doi.org/10.1002/alz.14286
Publication Date
Carmona-Iragui, M., O’Connor, A., Llibre-Guerra, J., Lao, P., Ashton, N. J., Fortea, J., & Sánchez-Valle, R. (2024). Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer’s disease and Down syndrome. EBioMedicine, 108, 105327. https://doi.org/10.1016/j.ebiom.2024.105327
Publication Date
Tahmi, M., Rippon, B., Palta, P., Sherwood, G., Hernandez, G., Soto, L., Cespedes, S., Pardo, M., Laing, K., Igwe, K., Johnson, A., Tomljanovic, Z., He, H., Gutierrez, J., Teresi, J. A., Moreno, H., Kreisl, W., Razlighi, Q., Brickman, A. M., & Luchsinger, J. A. (2024). Relationship Between Alzheimer Disease Imaging Biomarkers and Performance on the NIH Toolbox Cognition Battery in Late-middle Age Hispanics. Alzheimer Disease & Associated Disorders, 38(4), 311–318. https://doi.org/10.1097/wad.0000000000000641
Publication Date
Sewell, K. R., Doecke, J. D., Xiong, C., Benzinger, T., Masters, C. L., Laske, C., Jucker, M., Lopera, F., Gordon, B. A., Llibre‐Guerra, J., Levin, J., Huey, E. D., Hassenstab, J., Schofield, P. R., Day, G. S., Fox, N. C., Chhatwal, J., Ibanez, L., … Roh, J. H. (2024). Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia, 20(11), 7923–7939. Portico. https://doi.org/10.1002/alz.14270
Publication Date